- Published at
- by yahoo.com
mixed
mixed
CNS Pharmaceuticals Berubicin Trial is On Schedule to Commence in March 2021
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (
News for WPD PHARMACEUTICALS (8SV1.HA)
- Published at
- by benzinga.com
mixedmixedWPD Pharmaceuticals Announces Berubicin Supply Agreement for the Upcoming Clinical Trials
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD" or the "Company") today announced that ...- Published at
- by markets.businessinsider.com
positivepositiveWPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study
WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a multicenter pediatric malignant glioma P...- Published at
- by benzinga.com
mixedmixedWPD Pharmaceuticals Contracts Clinigen Clinical Supplies Management to Perform QP Certification of Berubicin for the Clinical Trials Authorization
VANCOUVER, British Columbia, Jan. 14, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE:WBIO)(FSE: 8SV1) (the "Company" or "WPD") a clinical-stage ...- Published at
- by investorideas.com
mixedmixedAI Eye Podcast 506: Rush University Medical Expands Use of Nuance (NasdaqGS: $NUAN) DAX
Point Roberts, WA and Vancouver, BC - January 8, 2021 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global investor news source cove...